Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 17NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Neoplasms 1Melanoma 1Lymphoma, Follicular 1Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 388Specimen Handling 377Magnetic Resonance Spectroscopy 328Radiotherapy 306Biopsy 273Cisplatin 258Carboplatin 255Paclitaxel 235Doxorubicin 226Fluorouracil 200Etoposide 197Vincristine 183Bevacizumab 181Filgrastim 170Gemcitabine 163Leucovorin 149Cytarabine 144aldesleukin 141Taxes 127Docetaxel 122Chemotherapy, Adjuvant 114Oxaliplatin 113fludarabine phosphate 111Methotrexate 108Rituximab 107Radiation 106Bortezomib 105Prednisone 102Irinotecan 100Dexamethasone 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × saponin QA-21V1 × Clear all
NCT00001572 2017-07-02

Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
21 enrolled
Lymphoid

Lymphoma, Follicular, Neoplasms, Lymphoma, B-Cell

NCT00005052 2009-02-09

Vaccine Therapy in Treating Patients With Primary Stage II Melanoma

National Cancer Institute (NCI)

Phase 3 Unknown
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡